Seed · AI & Machine Learning · Copenhagen, Denmark · Founded 2018 · 10–24 employees
Abzu is a deep tech startup that develops explainable AI for pharmaceutical and biotech companies, focusing on drug discovery and development. Their proprietary QLattice technology is based on quantum mechanics and neural networks, providing transparent and trustworthy AI models that accelerate analysis and insights. The company has received €13.3M in total funding and has been recognized by Gartner as a Cool Vendor. Founded in 2018 with offices in both Copenhagen and Barcelona, Abzu won the 2023 Best HealthTech Nordics Award and is advancing RNA therapeutics and drug design through their AI-powered platform.
No open roles listed right now.